Home » Stocks » TNXP

Tonix Pharmaceuticals Holding Corp. (TNXP)

Stock Price: $0.980 USD -0.030 (-2.97%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Pre-market: $0.659 -0.321 (-32.76%) Jul 26, 8:53 AM
Market Cap 323.93M
Revenue (ttm) n/a
Net Income (ttm) -63.84M
Shares Out 290.11M
EPS (ttm) -0.40
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $0.980
Previous Close $1.010
Change ($) -0.030
Change (%) -2.97%
Day's Open 1.010
Day's Range 0.980 - 1.030
Day's Volume 1,615,829
52-Week Range 0.510 - 2.120

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Following an unblinded, pre-planned interim analysis by the Independent Data Monitoring Committee (IDMC), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) will stop enrollment in the Phase 3 RALLY stud...

2 hours ago - Benzinga

RALLY Study Will Stop Enrolling New Participants Following Recommendation from an Interim Analysis Indicating Inadequate Separation from Placebo at Week-14 in the First 50% of Participants, Based on the...

2 days ago - GlobeNewsWire

Trending penny stocks can be a great addition to your watchlist, here's 7 popular small-caps for your list The post Popular Penny Stocks to Buy Right Now? 7 For Your Watchlist appeared first on Penny St...

Other stocks mentioned: BRN, HUT, IBIO, REI, URG, WTI
3 weeks ago - PennyStocks

Making a penny stocks watchlist for July? Check these 8 out The post Penny Stocks To Buy in 2021?

Other stocks mentioned: ABEV, AUUD, ZOM, EVFM, LKCO, TELL, XELA
3 weeks ago - PennyStocks

Are these hot penny stocks on your morning watchlist? The post Best Penny Stocks to Buy Right Now?

Other stocks mentioned: MRIN, SB, UAMY, ABUS, AHT, SENS
4 weeks ago - PennyStocks

CHATHAM, N.J., June 28, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Tonix was add...

4 weeks ago - GlobeNewsWire

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) said in a regulatory filing that plans are underway to construct a commercial-scale manufacturing site to develop and manufacture vaccines, including it...

1 month ago - Benzinga

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) plans to develop TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for Long COVID Syndrome (Long COVID), which is now known officially as Post-Acute S...

1 month ago - Benzinga

Long COVID Symptoms of Pain, Sleep Disturbance, Fatigue and Brain Fog Overlap with Symptoms of Fibromyalgia, for which TNX-102 SL is in Mid-Phase 3 Development

1 month ago - GlobeNewsWire

CHATHAM, N.J., June 16, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

1 month ago - GlobeNewsWire

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced the poster presentation of previously reported results from its Phase 3 RELIEF trial evaluating the TNX-102 SL tablet for the management o...

1 month ago - Benzinga

Shares of these biotechs have been soaring in the opposite direction of their peers.

Other stocks mentioned: BCRX
2 months ago - The Motley Fool

Lots of irons in the fire could be distracting investors from the most serious problem this company faces right now.

2 months ago - The Motley Fool

CHATHAM, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman, ...

2 months ago - GlobeNewsWire

Announced Positive Efficacy Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800

2 months ago - GlobeNewsWire

This biotech's ambitious development pipeline keeps attracting attention.

2 months ago - The Motley Fool

CHATHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

3 months ago - GlobeNewsWire

There is a good chance Tonix Pharmaceuticals (NASDAQ:TNXP) breaks the support at $1 and moves lower. There's support at this level because it's important psychologically.

3 months ago - Benzinga

Finding trending penny stocks can be a great place to start making a watchlist; here's 3 to consider The post 4 Trending Penny Stocks to Watch on Monday, April 19th appeared first on Penny Stocks to Buy...

Other stocks mentioned: TBLT, TRCH, XXII
3 months ago - PennyStocks

TNXP stock is up today with news that the company is joining with a biotech company to commercialize a new coronavirus therapy. The post TNXP Stock: The Huge Covid-19 News Boosting Tonix Pharmaceuticals...

3 months ago - InvestorPlace

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and privately-held OyaGen Inc have entered into an exclusive worldwide licensing agreement for TNX-3500 (sangivamycin, formerly OYA1) for the treatment ...

3 months ago - Benzinga

These high-risk, high-reward healthcare stocks have outperformed the market over the past year.

Other stocks mentioned: TRVN
3 months ago - The Motley Fool

CHATHAM, N.J., April 07, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

3 months ago - GlobeNewsWire

Company Expects to Initiate a Phase 2 Clinical Trial in the Fourth Quarter of 2021, Pending Results of Toxicology Studies Company Expects to Initiate a Phase 2 Clinical Trial in the Fourth Quarter of 20...

4 months ago - GlobeNewsWire

CHATHAM, N.J., March 19, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the U.S. Pat...

4 months ago - GlobeNewsWire

Amid risk-on sentiment, penny stocks are surging higher today as investors seek to grab the higher upside these small-cap stocks provide. The post Top Penny Stocks News Today: TNXP, ONTX, AREC, LPCN and...

Other stocks mentioned: AREC, LPCN, ONTX, ZCMD
4 months ago - InvestorPlace

The company reported positive results from a pre-clinical study.

4 months ago - The Motley Fool

Tonix Pharmaceuticals (TNXP) stock is soaring higher after the company provided an update on its vaccine for the novel coronavirus. The post TNXP Stock: Why Tonix Pharmaceuticals Shares Are Soaring Toda...

4 months ago - InvestorPlace

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) jumps in premarket trading after announcing positive preliminary results following vaccination of non-human primates with TNX-1800, its COVID-19 vaccine...

4 months ago - Benzinga

Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission

4 months ago - GlobeNewsWire

Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia

4 months ago - GlobeNewsWire

If you're in the market for a clinical-stage biotechnology stock that has a Covid-19 association and much more, then check out TNXP stock. The post Try Tonix Pharmaceuticals as Packed Pipeline Addresses...

4 months ago - InvestorPlace

CHATHAM, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has regai...

4 months ago - GlobeNewsWire

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has licensed technology using oxytocin-based therapeutics from the French National Institute of Health and Medical Research (Inserm) for the treatment o...

5 months ago - Benzinga

Expands Proprietary Uses of Tonix's Potentiated Oxytocin for Intranasal Administration

5 months ago - GlobeNewsWire

CHATHAM, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

5 months ago - GlobeNewsWire

CHATHAM, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing o...

5 months ago - GlobeNewsWire

The biotech wants to help doctors measure T-cell immunity to the novel coronavirus.

5 months ago - The Motley Fool

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has entered into a securities purchase agreement with institutional investors to purchase 58.3 million shares at $1.20 per share, raising gross proceeds...

5 months ago - Benzinga

CHATHAM, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced it has entere...

5 months ago - GlobeNewsWire

Annovis Bio (NYSE: ANVS) shares were trading higher Thursday after the company announced the European Patent Office granted the company's patent for a method of treating acute nerve and brain injuries b...

Other stocks mentioned: ANVS
5 months ago - Benzinga

TNXP stock is on the move today as investors speculate over potential patent approval and Tonix's drug candidate for Alzheimer's. The post TNXP Stock: Why Tonix Pharmaceuticals Shares Are on the Move To...

5 months ago - InvestorPlace

Tonix Pharmaceuticals was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. The information contained in this article in no way represents investmen...

5 months ago - Benzinga

GMP Production of TNX-1500 is Expected to be Available in the Third Quarter of 2021

6 months ago - GlobeNewsWire

CHATHAM, N.J., Jan. 13, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing o...

6 months ago - GlobeNewsWire

CHATHAM, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced it has entere...

6 months ago - GlobeNewsWire

CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

6 months ago - GlobeNewsWire

This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penny stocks?

Other stocks mentioned: BIOL, JAGX, SENS
7 months ago - Benzinga

Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19

7 months ago - GlobeNewsWire

University of Geneva Technology Covers Broad Applications for Cardiometabolic Syndromes University of Geneva Technology Covers Broad Applications for Cardiometabolic Syndromes

7 months ago - GlobeNewsWire

About TNXP

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases; and central nervous system (CNS) product candidates comprise small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The company's lead... [Read more...]

Industry
Biotechnology
Founded
2007
CEO
Seth Lederman
Employees
26
Stock Exchange
NASDAQ
Ticker Symbol
TNXP
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for TNXP stock is "Strong Buy" and the 12-month stock price forecast is 4.25.

Price Target
$4.25
Analyst Consensus: Strong Buy